VolitionRX Limited VNRX Q2 2026 earnings

FAQ

When did VolitionRX Limited report Q2 2026 earnings?

VolitionRX Limited (VNRX) reported Q2 2026 earnings on August 13, 2026 after market close.

What were VolitionRX Limited's Q2 2026 revenue and EPS?

VolitionRX Limited reported revenue of $398.7K and eps of $-0.85 for Q2 2026.

Did VolitionRX Limited beat estimates in Q2 2026?

Revenue missed the consensus estimate of $415.3K by $16.6K. EPS missed the consensus estimate of $-0.57 by $0.28.

How did VolitionRX Limited's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 2.0% from $406.7K a year earlier and eps declined 1316.7% from $-0.06.

Where can I find VolitionRX Limited's Q2 2026 SEC filings?

You can read the 8-K earnings release (0001477932-26-004991) and the 10-Q periodic report (0001477932-26-004995) directly on SEC EDGAR. The filing index links above go to sec.gov.